LOCKSTOWN PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: M91021 | WILLENHALL, WV13 2DR
Showing results 451-500 of 604
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Olopatadine | 25 | 150 | £145 | -43.0% ▼ |
| Azelaic acid | 25 | 810 | £115 | +4.6% ▲ |
| Terbinafine hydrochloride | 25 | 885 | £165 | -32.6% ▼ |
| 25 | 226 | £2.8K | +174.4% ▲ | |
| 25 | 500 | £150 | -42.0% ▼ | |
| 25 | 150 | £250 | +171.5% ▲ | |
| Ticagrelor | 24 | 1,344 | £1.3K | -71.8% ▼ |
| Flupentixol hydrochloride | 24 | 980 | £59 | -26.7% ▼ |
| Fesoterodine fumarate | 24 | 896 | £75 | -39.2% ▼ |
| 24 | 439 | £50 | -51.9% ▼ | |
| 24 | 2,200 | £152 | -12.7% ▼ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 23 | 812 | £118 | -33.9% ▼ |
| Bempedoic acid/Ezetimibe | 23 | 812 | £1.5K | -62.3% ▼ |
| Acamprosate calcium | 23 | 2,296 | £260 | -34.0% ▼ |
| Acetylcysteine | 23 | 230 | £1.8K | +127.0% ▲ |
| Zinc oxide | 22 | 603 | £73 | +6.3% ▲ |
| Bezafibrate | 22 | 1,568 | £167 | -59.2% ▼ |
| Levomepromazine hydrochloride | 22 | 170 | £326 | -4.4% ▼ |
| Tapentadol | 22 | 1,232 | £1.0K | -46.6% ▼ |
| Midazolam hydrochloride | 22 | 96 | £2.2K | +52.7% ▲ |
| Clindamycin hydrochloride | 22 | 2,352 | £503 | +119.7% ▲ |
| Empagliflozin/metformin | 22 | 1,092 | £679 | -57.7% ▼ |
| Estradiol valerate | 22 | 2,352 | £194 | +12.6% ▲ |
| Tibolone | 22 | 840 | £78 | -28.1% ▼ |
| Powder 3.7 kcal/g energy and protein fortifier (0913081) | 22 | 930 | £2.2K | +252.7% ▲ |
| Other barrier preparations | 22 | 2,430 | £257 | +271.8% ▲ |
| Pimecrolimus | 22 | 900 | £541 | +29.9% ▲ |
| Diclofenac sodium | 22 | 1,200 | £874 | -8.2% ▼ |
| Imipramine hydrochloride | 21 | 3,052 | £115 | -17.6% ▼ |
| Exenatide | 21 | 78 | £1.8K | +19.8% ▲ |
| Mycophenolate mofetil | 21 | 2,072 | £237 | -48.1% ▼ |
| Calcium acetate | 21 | 1,764 | £127 | +13.5% ▲ |
| RtS 2.4 kcal/ml milkshake lower volume with fibre (0913021) | 21 | 113.8K | £4.2K | +124.0% ▲ |
| Dorzolamide | 21 | 200 | £177 | -74.7% ▼ |
| Permethrin | 21 | 1,290 | £384 | -44.3% ▼ |
| 21 | 230 | £620 | -56.1% ▼ | |
| 21 | 115 | £354 | +155.9% ▲ | |
| Lurasidone | 20 | 560 | £1.5K | -19.8% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 20 | 820 | £1.2K | +81.2% ▲ |
| Primidone | 20 | 1,680 | £2.1K | -43.8% ▼ |
| Testosterone undecanoate | 20 | 20 | £1.7K | -21.2% ▼ |
| 20 | 42 | £253 | -44.0% ▼ | |
| 20 | 910 | £4.5K | +58.1% ▲ | |
| 20 | 750 | £1.6K | +41.3% ▲ | |
| Irbesartan with diuretic | 19 | 1,064 | £365 | +20.8% ▲ |
| Rizatriptan | 19 | 120 | £426 | -68.0% ▼ |
| Fosfomycin trometamol | 19 | 43 | £199 | -33.2% ▼ |
| Rifampicin | 19 | 1,056 | £788 | +231.5% ▲ |
| Alfuzosin hydrochloride | 19 | 1,300 | £449 | -73.4% ▼ |
| Sodium chloride | 19 | 740 | £264 | +187.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.